HOXC9 Polyclonal Antibody from Bioss Inc.

Yes, the HOXC9 Polyclonal Antibody has been utilized in research to evaluate the expression of HOXC9 in neuroblastoma cell lines, particularly in studies assessing the response to retinoid treatment. The antibody was part of a comparative analysis of protein biomarkers associated with sensitivity or resistance to retinoids in these cell lines, as documented in the study by Dobrotko et al. (2019) dobrotko2019.

The HOXC9 Polyclonal Antibody has been shown to work in various applications including Western Blotting, ELISA, Immunocytochemistry, Immunofluorescence, and both frozen and paraffin-embedded Immunohistochemistry. This versatility allows for its use in different experimental setups to study HOXC9 expression.

In the context of immunofluorescence, the HOXC9 Polyclonal Antibody has been cited at a dilution of 1:200 in a study that involved staining for adipocytes, indicating that this dilution may be effective for similar applications xu2023.

The HOXC9 Polyclonal Antibody is reactive with Homo sapiens (human), making it suitable for studies involving human tissues. Its application in human colorectal cancer and other human-derived samples has been documented, supporting its relevance in human biological research.